ECSP099536A - Métodos y formulaciones para biodisponibilidad mejorada de antiprogestinas - Google Patents

Métodos y formulaciones para biodisponibilidad mejorada de antiprogestinas

Info

Publication number
ECSP099536A
ECSP099536A EC2009009536A ECSP099536A ECSP099536A EC SP099536 A ECSP099536 A EC SP099536A EC 2009009536 A EC2009009536 A EC 2009009536A EC SP099536 A ECSP099536 A EC SP099536A EC SP099536 A ECSP099536 A EC SP099536A
Authority
EC
Ecuador
Prior art keywords
antiprogestines
formulations
methods
improved
biodisponibility
Prior art date
Application number
EC2009009536A
Other languages
English (en)
Inventor
Joseph Podolski
Original Assignee
Repros Therapeutis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repros Therapeutis Inc filed Critical Repros Therapeutis Inc
Publication of ECSP099536A publication Critical patent/ECSP099536A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

La presente invención se refiere en términos generales a composiciones con biodisponibilidad mejorada que comprenden por lo menos una antiprogestina. Más particularmente, la invención presente se relaciona con una potente actividad antiporgestacional, actividad antiglucocorticoide mínima y biodisponibilidad mejorada, comprendiendo un derivado de 19-norprogesterona I y opcionalmente un excipiente farmacéuticamente aceptable.
EC2009009536A 2006-12-28 2009-07-23 Métodos y formulaciones para biodisponibilidad mejorada de antiprogestinas ECSP099536A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88242306P 2006-12-28 2006-12-28
US88537207P 2007-01-17 2007-01-17

Publications (1)

Publication Number Publication Date
ECSP099536A true ECSP099536A (es) 2009-08-28

Family

ID=39589194

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2009009536A ECSP099536A (es) 2006-12-28 2009-07-23 Métodos y formulaciones para biodisponibilidad mejorada de antiprogestinas

Country Status (14)

Country Link
EP (1) EP2094275A2 (es)
JP (1) JP2010514793A (es)
KR (1) KR20090086470A (es)
AR (1) AR064697A1 (es)
AU (1) AU2007339820A1 (es)
CA (1) CA2672888A1 (es)
CL (1) CL2007003855A1 (es)
CO (1) CO6190605A2 (es)
EA (1) EA200970646A1 (es)
EC (1) ECSP099536A (es)
MX (1) MX2009006912A (es)
NO (1) NO20092271L (es)
TW (1) TW200831110A (es)
WO (1) WO2008083192A2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8299050B2 (en) * 2008-01-29 2012-10-30 Laboratoire Hra-Pharma Method for treating uterine fibroids
US8512745B2 (en) 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
EP3106167A1 (en) 2009-04-14 2016-12-21 Laboratoire HRA Pharma Method for on-demand contraception
EP2471537A1 (en) * 2010-12-30 2012-07-04 PregLem S.A. Treatment of pain associated with dislocation of basal endometrium
EP2545922A1 (en) 2011-07-12 2013-01-16 PregLem S.A. Treatment of excessive menstrual bleeding associated with uterine fibroids
EP2775831A4 (en) * 2011-10-21 2015-08-12 Seachaid Pharmaceuticals Inc PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
FR2997627B1 (fr) * 2012-11-08 2015-01-16 Hra Pharma Lab Produit de co-micronisation comprenant de l'ulipristal acetate
FR2997628B1 (fr) * 2012-11-08 2015-01-16 Hra Pharma Lab Produit de co-micronisation comprenant un modulateur selectif des recepteurs a la progesterone
FR2999081B1 (fr) * 2012-12-06 2015-02-27 Hra Pharma Lab Dispersion solide d'un modulateur selectif du recepteur a la progesterone
BR112015025954A2 (pt) 2013-04-10 2017-07-25 Preglem Sa moduladores do receptor de progesterona para utilização na terapia de fibroides uterinos
US20200069702A1 (en) * 2016-12-09 2020-03-05 Repros Therapeutics Inc. Oral pharmaceutical compositions comprising an unmicronized selective progesterone receptor as active agent
WO2017216637A2 (en) 2017-08-04 2017-12-21 Alvogen Malta Operations (Row) Ltd Tablet form including ulipristal acetate and the methods for its preparation
WO2023033900A1 (en) 2021-09-06 2023-03-09 Slayback Pharma Llc Pharmaceutical compositions of mifepristone

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT900234E (pt) * 1996-05-01 2000-12-29 Us Gov Health & Human Serv Derivados de progesterona substituidos em 21 que podem ser utilizados como novos agentes antiprogestativos
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
FR2821555B1 (fr) * 2001-03-01 2003-05-16 Besins Int Lab Progestatif co-micronise avec un tensioactif, composition pharmaceutique le comprenant, leurs procedes de fabrication et leurs utilisations
US20050220825A1 (en) * 2004-03-10 2005-10-06 Adrian Funke Molecular dispersions of drospirenone
CA2623678A1 (en) * 2005-09-29 2007-04-05 Repros Therapeutics Inc. Formulations with improved bioavailability, comprising a steroid derivative and a polyglycolysed glyceride

Also Published As

Publication number Publication date
JP2010514793A (ja) 2010-05-06
CA2672888A1 (en) 2008-07-10
MX2009006912A (es) 2009-08-12
AU2007339820A1 (en) 2008-07-10
CL2007003855A1 (es) 2008-03-14
KR20090086470A (ko) 2009-08-12
AR064697A1 (es) 2009-04-22
WO2008083192A8 (en) 2009-07-09
WO2008083192A3 (en) 2008-11-27
CO6190605A2 (es) 2010-08-19
EP2094275A2 (en) 2009-09-02
WO2008083192A2 (en) 2008-07-10
EA200970646A1 (ru) 2009-12-30
NO20092271L (no) 2009-08-06
TW200831110A (en) 2008-08-01

Similar Documents

Publication Publication Date Title
ECSP099536A (es) Métodos y formulaciones para biodisponibilidad mejorada de antiprogestinas
MX2009010289A (es) Composiciones para administracion nasal.
IL192948A0 (en) Novel pyridine derivatives
NO20076613L (no) Farmasoytiske formuleringer og anvendelse derav
MY154909A (en) Novel thiophene derivatives
IL247485A0 (en) Estrogen preparations for vaginal administration
PT2344198T (pt) Preparações farmacêuticas à base de lípidos para aplicação tópica
IL184394A0 (en) Bendamustine pharmaceutical compositions for lyophilisation
TW200700406A (en) Novel thiophene derivatives
WO2007106537A3 (en) Aminoquinolones as gsk-3 inhibitors
TW200716591A (en) Novel thiophene derivatives
IL247484A0 (en) Gel preparations for local administration
MX2007003342A (es) Compuestos para inflamacion y usos relacionados con trastornos inmunitarios.
IL188043A0 (en) Estrogen compositions for vaginal administration
TW200716552A (en) Novel thiophene derivatives
BRPI0509184A (pt) composições farmacêuticas
TW200738670A (en) Novel thiophene derivatives
WO2005067893A3 (en) Pharmaceutical compositions comprising midazolam in a high concentration
ZA201004654B (en) Phenylephrine pharmaceutical formulations and compositions for transmucosal absorption
GT200800107A (es) Formulaciones orales que comprenden tigeciclina
WO2008103847A3 (en) Bridged polycyclic compound based compositions for the inhibition and amelioration of disease
ZA200705793B (en) Bendamustine pharmaceutical compositions for lyophilisation
WO2009035634A3 (en) Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors
DOP2009000262A (es) Una composicion de liberacion prolongada que comprende un derivado de somatostatina en microparticulas
IL182505A0 (en) Purified phospholipid-non-steroidal, anti-inflammatory drug associated compositions and method for preparing and using same